Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride for Ineffective Esophageal Motility (IEMPru)
NCT03244553Phase 2Completed
- Sponsor
- University of Calgary
- Start
- Oct 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prucalopride in Ineffective Esophageal Motility (IEM), sponsored by University of Calgary. Started Oct 2017; status: completed.
02
Drugs
prucalopride
03
Conditions
Ineffective Esophageal Motility (IEM)
Beyond the preview
Go deeper on NCT03244553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03244553.